Product References — Animal Blood Cells

Sensitive and Rapid UHPLC–MS/MS Assay for Simultaneous Quantifications of Calcipotriol and Paclitaxel in Rat Whole Blood and Plasma Samples

Posted by Adam Awdish on

Sensitive and Rapid UHPLC–MS/MS Assay for Simultaneous Quantifications of Calcipotriol and Paclitaxel in Rat Whole Blood and Plasma Samples

Innovative Grade US Origin Rat Sprague Dawley Whole Blood and Innovative Grade US Origin Rat Sprague Dawley Plasma from Innovative Research was used in the following study:   Sensitive and Rapid UHPLC–MS/MS Assay for Simultaneous Quantifications of Calcipotriol and Paclitaxel in Rat Whole Blood and Plasma Samples Victor R. Lincha, Cheng-Hui Hsiao, Jun Zhao, Chun Li, Diana S-L Chow Journal of Pharmaceutical and Biomedical Analysis October 9, 2020 The potential benefits of stroma-depleting agents combined with chemotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment has been examined in vitro and in transplantation studies. Unfortunately, this type of treatment has failed in...

Read more →

Biomimetic Anisotropic Polymeric Nanoparticles Coated with Red Blood Cell Membranes for Enhanced Circulation and Toxin Removal

Posted by Adam Awdish on

Biomimetic Anisotropic Polymeric Nanoparticles Coated with Red Blood Cell Membranes for Enhanced Circulation and Toxin Removal

Innovative Grade US Origin Mouse CD1 Whole Blood from Innovative Research was used in the following study:   Biomimetic Anisotropic Polymeric Nanoparticles Coated with Red Blood Cell Membranes for Enhanced Circulation and Toxin Removal Elana Ben-Akiva, Randall A. Meyer, Hongzhe Yu, Jonathan T. Smith, Drew M. Pardoll, Jordan J. Green Science Advances April 15, 2020 Therapeutic devices based on biomaterials can have enhanced function due to mimicry of naturally occurring structures. Cell membrane coatings can be used to mimic the functionality of various cell types, enhancing delivery properties, and extending the half-life of blood circulation. However, previous studies have used...

Read more →

Supramolecular Assembly of Toll-like Receptor 7/8 Agonist into Multimeric Water-Soluble Constructs Enables Superior Immune Stimulation In Vitro and In Vivo

Posted by Adam Awdish on

Supramolecular Assembly of Toll-like Receptor 7/8 Agonist into Multimeric Water-Soluble Constructs Enables Superior Immune Stimulation In Vitro and In Vivo

Porcine Red Blood Cells Packed 10% from Innovative Research was used in the following study:   Supramolecular Assembly of Toll-like Receptor 7/8 Agonist into Multimeric Water-Soluble Constructs Enables Superior Immune Stimulation In Vitro and In Vivo Alexander K. Andrianov, Alexander Marin, Ruixue Wang, Hatice Karauzum, Ananda Chowdhury, Pragati Agnihotri, Abdul S. Yunus, Roy A. Mariuzza, and Thomas R. Fuerst ACS Applied Bio Materials April 8, 2020 The magnitude to which a pathogen triggers an immune response depends largely on the activation of specific pattern recognition receptors (PRR), particularly Toll-like receptors (TLRs), expressed by cells at the infection site. TLR7/8 agonists...

Read more →

Efficacy of Antimicrobial Interventions in Reducing Salmonella enterica, Shiga Toxin-Producing Escherichia coli, Campylobacter, and Escherichia coli Biotype I Surrogates on Non-Chilled and Chilled, Skin-on and Skinless Pork

Posted by Adam Awdish on

Efficacy of Antimicrobial Interventions in Reducing Salmonella enterica, Shiga Toxin-Producing Escherichia coli, Campylobacter, and Escherichia coli Biotype I Surrogates on Non-Chilled and Chilled, Skin-on and Skinless Pork

Innovative Grade US Origin Horse Whole Blood Laked from Innovative Research was used in the following study:   Efficacy of Antimicrobial Interventions in Reducing Salmonella enterica, Shiga Toxin-Producing Escherichia coli, Campylobacter, and Escherichia coli Biotype I Surrogates on Non-Chilled and Chilled, Skin-on and Skinless Pork L.C. Eastwood, T.M. Taylor, J.W. Savell, K.B. Gehring, A.N. Arnold Meat Science September 13, 2020 According to 2018 data from the CDC, about 48 million people become ill, 128,000 are hospitalized, and 3,000 people die from foodborne diseases yearly in the United States, with non-typhoidal salmonellae being reported as the most prevalent cause for these...

Read more →

Immunotherapy Targeting the Streptococcus Pyogenes M Protein or Streptolysin O to Treat or Prevent Influenza A Superinfection

Posted by Adam Awdish on

Immunotherapy Targeting the Streptococcus Pyogenes M Protein or Streptolysin O to Treat or Prevent Influenza A Superinfection

Rabbit Red Blood Cells from Innovative Research was used in the following study:   Immunotherapy Targeting the Streptococcus Pyogenes M Protein or Streptolysin O to Treat or Prevent Influenza A Superinfection Andrea L. Herrera, Christopher Van Hove, Mary Hanson, James B. Dale, Rodney K. Tweten, Victor C. Huber, Diego Diel, Michael S. Chaussee PLoS ONE June 23, 2020 Infection with influenza A virus (IAV) creates a permissive environment for secondary bacterial infections (often referred to as superinfections), which significantly increases the morbidity and mortality associated with both IAV epidemics and pandemics. Streptococcus pyogenes (the group A Streptococcus, GAS) typically causes...

Read more →


×